Terms

3TC
2', 3'-dideoxy-3'-thiacytidine (Lamivudine)
ACT
Artemisinin Combination Therapies
AHI
Acute HIV Infection
ANC
Antenatal Clinics
APN+
Asian Pacific Network of People Living with HIV/AIDS
ART
Antiretroviral Therapy
ARV
Antiretroviral(s)
ASRH
Adolescent Sexual and Reproductive Health
AYA
African Youth Alliance
AZT
Azido-deoxythymidine
cART
Combination Antiretroviral Therapy
CBO
Community Based Organizations
CDC
Centers for Disease Control
CEDAW
Convention on the Elimination of All Forms of Discrimination Against Women
C-section
Cesarean Section
d4T/3TC/NVP
Stavudine, Lamivudine and Nevirapine
DDL
Didanosine
DHS
Demographic and Health Surveys
DMPA
Depot-medroxyprogesterone Acetate
DOT
Directly Observed Therapy
DOTS-SC
Directly Observed Therapy Short Course
DRC
Democratic Republic of the Congo
EFV
Efavirenz
FC2
Female Condom
FP
Family Planning
FSW
Female Sex Workers
GAA
Global AIDS Alliance
GBV
Gender-Based Violence
GFATM
Global Fund on AIDS, Tuberculosis and Malaria
GHESKIO
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections
GUD
Genital Ulcer Disease
HAART
Highly active antiretroviral therapy
HRW
Human Rights Watch
HSV-2
Herpes Simplex Virus Type 2
HTC
HIV Testing and Counseling
ICRW
International Center for Research on Women
ICW
International Community of Women Living with HIV/AIDS
IDP
Internally Displaced Persons
IDU
Injecting Drug Users
IEC
Information Education and Communication
ILO
International Labor Organization
IP/PP
Intrapartum/postpartum
IPT
Intermittent Preventive Treatment
IPV
Intimate Partner Violence
IOM
Institute of Medicine
IRC
International Rescue Committee
IRIS
Immune Reconstitution Inflammatory Response
ITN
Insecticide Treated Nets
IU
In utero
LBW
Low Birth Weight
LPR/r
Lopinavir/ritonavir
MCH
Maternal and Child Health
MDG
U.N. Millennium Development Goals
mDOT
Modified Directly Observed Therapy
MDR-TB
Multi-Drug-Resistant Tuberculosis
ML
Milliliter
MNCH
Maternal-Newborn-Child-Health
MSM
Men Who Have Sex with Men
M&E
Monitoring and Evaluation
NGO
Non-governmental Organization
NH
Non-hormonal
NNRTI
Non-nucleoside Reverse Transcriptase Inhibitor
NVP
Nevirapine
OC
Oral Contraceptive
OSI
Open Society Institute
OST
Opioid Substitution Treatment
OVC
Orphans and Vulnerable Children
PAC
Population Action Committee
PCR
Polymerase Chain Reaction
PEP
Post-Exposure Prophylaxis
PHA
Peer Health Advocate
PHR
Physicians for Human Rights
PID
Pelvic Inflammatory Disease
PLHA
People Living with HIV/AIDS
PMTCT
Preventing Mother-to-Child Transmission of HIV
PPE
Personal Protective Equipment
PPT
Preventing of Perinatal Transmission
PR
Principal Recipients
PT
Preventive Therapy
PRB
Population Reference Bureau
PYs
Person-Years
RCT
Randomized Controlled Trial
RH
Reproductive Health
RHT
Routine HIV Testing
RHR
Reproductive Health for Refugees
RTI
Reproductive Tract Infection
SIL
Squamous Intraepithelial Lesion
Sd NVP
Single-dose-nevirapine
SP
Sulfadoxine-pyrimethamine
SRH
Sexual and Reproductive Health
SRHR
Sexual and Reproductive Health and Rights
STD
Sexually Transmitted Disease
STI
Sexually Transmitted Infection
TB
Tuberculosis
TERG
Technical Evaluation Reference Group
TRP
Technical Review Panel UN United Nations
UNAIDS
Joint United Nations Programme on HIV/AIDS
UNFPA
United Nations Population Fund
UNGASS
United Nations Programme on HIV/AIDS
UNICEF
United Nations Children’s Fund
UNODC
United Nations Office on Drugs and Crime
USAID
United States Agency for International Development
VAW
Violence Against Women
VCT
Voluntary Counseling and Testing
WHO
World Health Organization
XDR-TB
Extensively Drug Resistant TB
ZDV
Zidovudine
PWID
People Who Inject Drugs
MWID
Males Who Inject Drugs
FWID
Females Who Inject Drugs